You have successfully logged out.
Not registered yet?
Central Venous Catheter Certofix®
B. Braun offers a comprehensive portfolio of acute central venous catheter sets for both, adult and pediatric patients.
As your system partner for ultrasound-guided central line placement and ECG-guided catheter tip positioning, our goal is to make CVC placement safer
To adjust optimal skin fixation position with sutured or non-sutured fixation
Additionally to the lumen configurations and the non-coated catheters, B.Braun offers a Central Venous Catheter with Proven Non-leaching Antimicrobial Effect Durable over 30 Days – Certofix® protect.
*Krikava I, et al. The efficacy of a non-leaching antibacterial central venous catheter – a prospective, randomized,
double-blind study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):154-160.
from 4,200€ to
0€
CRBSIs create additional costs per episode ranged
include a number of different components dependent on the individual set configuration, such as Introducer Needles, a Nitinol Guidewire, Syringes, Scalpels, Dilator, ECG Cable, different kind of Needle-free connectors and fixation devices. B. Braun‘s Certofix® range is complemented by a number of Accessories to confirm CVC tip position during or after placement via Intraatrial ECG. Compatible with most commonly used ECG monitors.
[1] The Joint Commission. Preventing Central Line–Associated Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012. http://www.PreventingCLABSIs.pdf.
[2] https://ecdc.europa.eu/en/publications-data/directory-guidance-prevention-and-control/healthcare-associated-infections-1
[3] Yousif A, Jamal MA, Raad I. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol. 2015; 830:157-79
[4] Elliott TSJ. The pathogenesis and prevention of intravascular catheter-related infections. In: Hamilton H, Bodenham AR. Central venous catheters. Chichester [u.a.]: Wiley-Blackwell 2009; 206-209
[5] McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med. 2012 Feb; 40(2):388-93
[6] Krikava I, et al. The efficacy of a non-leaching antibacterial central venous catheter – a prospective, randomized, double-blind study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):154-160.
[7] Richards GA, et al. Investigation of biofilm formation on a charged intravenous catheter relative to that on a similar but uncharged catheter
[8] Brunke J, Riemann T, Roschke I, 30 days antimicrobial efficacy of non-leaching central venous catheters (Poster 063), Critical Care 2016, Volume 20 Suppl 2.
[9] Brunke J, et al. Quantitative comparision of the antimicrobial efficiency of leaching versus nonleaching polymer materials. Macromol. Biosci. 2016, 16, 647-654.
[10] Hanna H, et al. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006 Oct;50(10):3283-8
[11] Yasukawa T, Fujita Y, Sari A. Antimicrobialimpregnated central venous catheters. N Engl J Med. 1999 Jun 3; 340(22):1762
[12] Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology. 1997 Nov; 87(5):1242-4.
[13] Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47: 589-98
[14] Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22: 640-6
With your personalized account, your online experience will be easier, more comfortable and safe.